Novartis India Stock

Novartis India P/E 2024

Novartis India P/E

30.72

Ticker

500672.BO

ISIN

INE234A01025

As of Nov 1, 2024, Novartis India's P/E ratio was 30.72, a 80.49% change from the 17.02 P/E ratio recorded in the previous year.

The Novartis India P/E history

Novartis India Aktienanalyse

What does Novartis India do?

Novartis India ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Novartis India's P/E Ratio

The Price to Earnings (P/E) Ratio of Novartis India is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Novartis India's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Novartis India is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Novartis India’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Novartis India stock

What is the price-to-earnings ratio of Novartis India?

The price-earnings ratio of Novartis India is currently 30.72.

How has the price-earnings ratio of Novartis India changed compared to last year?

The price-to-earnings ratio of Novartis India has increased by 80.49% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Novartis India high compared to other companies?

Yes, the price-to-earnings ratio of Novartis India is high compared to other companies.

How does an increase in the price-earnings ratio of Novartis India affect the company?

An increase in the price-earnings ratio of Novartis India would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Novartis India affect the company?

A decrease in the price-earnings ratio of Novartis India would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Novartis India?

Some factors that influence the price-earnings ratio of Novartis India are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Novartis India pay?

Over the past 12 months, Novartis India paid a dividend of 25 INR . This corresponds to a dividend yield of about 2.36 %. For the coming 12 months, Novartis India is expected to pay a dividend of 25 INR.

What is the dividend yield of Novartis India?

The current dividend yield of Novartis India is 2.36 %.

When does Novartis India pay dividends?

Novartis India pays a quarterly dividend. This is distributed in the months of September, August, August, August.

How secure is the dividend of Novartis India?

Novartis India paid dividends every year for the past 4 years.

What is the dividend of Novartis India?

For the upcoming 12 months, dividends amounting to 25 INR are expected. This corresponds to a dividend yield of 2.36 %.

In which sector is Novartis India located?

Novartis India is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novartis India kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novartis India from 8/5/2024 amounting to 25 INR, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Novartis India pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Novartis India in the year 2023?

In the year 2023, Novartis India distributed 37.5 INR as dividends.

In which currency does Novartis India pay out the dividend?

The dividends of Novartis India are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Novartis India

Our stock analysis for Novartis India Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis India Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.